What will it take to end human suffering from measles?
by Kimberly M. Thompson, The Lancet Infectious Diseases 2017; DOI: http://dx.doi.org/10.1016/S1473-3099(17)30451-6 (published on-line August 11, 2017)
This editorial comments on the results of a dynamic measles tranmission model, similar to Kid Risk, Inc. dynamic measles and rubella transmission models and emphasizes that successfully achieving and maintaining national measles elimination
"depends on the identification and vaccination of
individuals unimmunised for measles, which means
that immunisation managers in all countries should
seek to identify the susceptible individuals living within their national borders, including those of all ages and
those not (well) covered by the national health system." The editorial highlights the current high costs and continuing disease burden associated with the global strategy of high control, and ends with the question of "Do we want to save future generations from measles (and rubella), or do we prefer the continuing health and economic burdens of ongoing transmission?"
Background on measles and rubella